Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Non-cash Items: 2019-2024

Historic Non-cash Items for Capricor Therapeutics (CAPR) over the last 6 years, with Dec 2024 value amounting to $101.8 million.

  • Capricor Therapeutics' Non-cash Items rose 653.98% to $101.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $101.8 million, marking a year-over-year increase of 653.98%. This contributed to the annual value of $101.8 million for FY2024, which is 653.98% up from last year.
  • According to the latest figures from FY2024, Capricor Therapeutics' Non-cash Items is $101.8 million, which was up 653.98% from $13.5 million recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Non-cash Items ranged from a high of $101.8 million in FY2024 and a low of $4.2 million during FY2020.
  • Over the past 3 years, Capricor Therapeutics' median Non-cash Items value was $13.5 million (recorded in 2023), while the average stood at $41.8 million.
  • Data for Capricor Therapeutics' Non-cash Items shows a peak YoY surged of 653.98% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Capricor Therapeutics' Non-cash Items stood at $4.2 million in 2020, then soared by 81.74% to $7.7 million in 2021, then spiked by 31.17% to $10.1 million in 2022, then spiked by 33.66% to $13.5 million in 2023, then surged by 653.98% to $101.8 million in 2024.